Risankizumab Biosimilar – Anti-IL23A mAb – Research Grade

Reference:
Size

,

Isotype

IgG1, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product nameRisankizumab Biosimilar - Anti-IL23A mAb - Research Grade
SourceCAS 1612838-76-2
SpeciesHumanized
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsRisankizumab,BI 655066,risankizumab-rzaa,IL23A,anti-IL23A
ReferencePX-TA1396
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Risankizumab Biosimilar - Anti-IL23A mAb - Research Grade

General information on Anti-IL23A[Homo sapiens] (Risankizumab) Monoclonal Antibody

Risankizumab is a humanized IgG1 monoclonal antibody (mAb) that targets interleukin 23 (IL-23). It has been used for the treatment of moderate-to-severe plaque psoriasis

SDS-PAGE for Risankizumab Biosimilar - Anti-IL23A mAb

Risankizumab Biosimilar - Anti-IL23A mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Risankizumab Biosimilar – Anti-IL23A mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Human IL23A recombinant protein
Antigen

Human IL23A recombinant protein

PX-P5123 131$
Human IgG1 LALA Isotype Control antibody (HyHEL-10)
Isotype Control

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

PTX17885 214$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products